PL3419683T3 - Preparaty i zestawy generujące tlenek azotu - Google Patents
Preparaty i zestawy generujące tlenek azotuInfo
- Publication number
- PL3419683T3 PL3419683T3 PL17757208T PL17757208T PL3419683T3 PL 3419683 T3 PL3419683 T3 PL 3419683T3 PL 17757208 T PL17757208 T PL 17757208T PL 17757208 T PL17757208 T PL 17757208T PL 3419683 T3 PL3419683 T3 PL 3419683T3
- Authority
- PL
- Poland
- Prior art keywords
- kits
- nitric oxide
- oxide generating
- generating formulations
- formulations
- Prior art date
Links
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 title 2
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662299850P | 2016-02-25 | 2016-02-25 | |
| PCT/US2017/019136 WO2017147295A1 (en) | 2016-02-25 | 2017-02-23 | Nitric oxide generating formulations and kits |
| EP17757208.8A EP3419683B1 (en) | 2016-02-25 | 2017-02-23 | Nitric oxide generating formulations and kits |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3419683T3 true PL3419683T3 (pl) | 2022-01-17 |
Family
ID=59686544
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17757208T PL3419683T3 (pl) | 2016-02-25 | 2017-02-23 | Preparaty i zestawy generujące tlenek azotu |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20190054038A1 (pl) |
| EP (1) | EP3419683B1 (pl) |
| JP (1) | JP7168958B2 (pl) |
| CN (2) | CN119185266A (pl) |
| AU (1) | AU2017223689B2 (pl) |
| ES (1) | ES2899364T3 (pl) |
| PL (1) | PL3419683T3 (pl) |
| WO (1) | WO2017147295A1 (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019169092A1 (en) * | 2018-03-01 | 2019-09-06 | The Regents Of The University Of Michigan | Two-part nitric oxide generating topical compositions |
| US20210386944A1 (en) * | 2018-10-12 | 2021-12-16 | Sanotize Research Development Corp. | Gas-evolving compositions and container and delivery systems |
| CA3141349A1 (en) * | 2019-06-10 | 2020-12-17 | The Regents Of The University Of Michigan | Catheter insert device with powder comprising s-nitrosothiol |
| US20210052842A1 (en) * | 2019-08-23 | 2021-02-25 | NOTA Laboratories, LLC | Nitric oxide generating systems for nasal inhalation |
| US11986597B2 (en) * | 2019-08-23 | 2024-05-21 | NOTA Laboratories, LLC | Nitric oxide generating systems for inhalation |
| CN114727915A (zh) * | 2019-10-07 | 2022-07-08 | 香榭有限公司 | 用于将一氧化氮递送至皮肤的组合物 |
| CN115279352A (zh) * | 2020-04-02 | 2022-11-01 | 密歇根大学董事会 | 尿导管治疗 |
| JP2023523410A (ja) * | 2020-04-22 | 2023-06-05 | サノタイズ リサーチ アンド ディベロップメント コープ. | 上気道感染症を治療するための組成物および方法 |
| US20240261243A1 (en) * | 2020-09-04 | 2024-08-08 | Know Bio, Llc | Nitric oxide donors, compositions, and methods of use |
| KR102602347B1 (ko) * | 2022-05-09 | 2023-11-15 | 천현수 | 위장내 발암성 엔-니트로사민 생성 억제 및 장내 산화질소 생성 촉진용 천연 조성물 및 이의 용도 |
| US20240188563A1 (en) * | 2022-12-09 | 2024-06-13 | Becton, Dickinson And Company | Catheter lock solutions incorporating nitric oxide releasing liposomes |
| CN116251166A (zh) * | 2023-01-18 | 2023-06-13 | 南京诺令生物科技有限公司 | 一种具有抗病毒功效的两相组合物及其应用 |
| US11813287B1 (en) * | 2023-03-10 | 2023-11-14 | King Faisal University | Covid-19 binding aerosols |
| WO2025159930A1 (en) * | 2024-01-26 | 2025-07-31 | University Of Georgia Research Foundation, Inc. | Lock solutions composed of a methanetrisdiazeniumdiolate salt and methods for making and using the same |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7678391B2 (en) * | 2000-04-26 | 2010-03-16 | Queen's University At Kingston | Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype |
| GB0022084D0 (en) * | 2000-09-08 | 2000-10-25 | Univ Aberdeen | Treatment of multiply antibiotic-resistant organisms |
| SE0300971D0 (sv) * | 2003-04-03 | 2003-04-03 | Aga Ab | Nitric oxide in treatment of inflammation |
| JP2009518069A (ja) * | 2005-12-02 | 2009-05-07 | ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミシガン | 組成物、コーティング及びデバイス、並びにそれらの製造方法及び使用方法 |
| US20090311292A1 (en) * | 2006-09-14 | 2009-12-17 | Cristalia Produtos Quimicos Farmaceuticos Ltda. | Process for synthesis and incorporation of nitric oxide donors in macromolecular compositions |
| WO2008153762A2 (en) * | 2007-05-25 | 2008-12-18 | N30 Pharmaceuticals, Llc | S-nitrosothiol formulations and storage systems |
| US8399005B2 (en) * | 2007-10-12 | 2013-03-19 | University Of North Carolina At Chapel Hill | Use of nitric oxide to enhance the efficacy of silver and other topical wound care agents |
| EP2237788A4 (en) * | 2007-12-27 | 2013-06-05 | Aires Pharmaceuticals Inc | COMPOUNDS FOR OBTAINING AEROSOLIZED NITRITE AND NITRIC OXIDE AND USES THEREOF |
| JP5351174B2 (ja) * | 2007-12-31 | 2013-11-27 | コヴィディエン リミテッド パートナーシップ | 消毒剤組成物、方法およびシステム |
| CN103127504A (zh) * | 2011-12-05 | 2013-06-05 | 尼奥克斯(文莱)控股有限公司 | 局部产生一氧化氮的组合物和方法 |
| US20150272988A1 (en) * | 2012-03-07 | 2015-10-01 | Advanced Inhalation Therapies (Ait) Ltd. | Inhalation of nitric oxide for treating respiratory diseases |
| WO2013169538A1 (en) * | 2012-05-08 | 2013-11-14 | Albert Einstein College Of Medicine Of Yeshiva University | Nanoparticle delivery vehicle for s-nitroso-n-acetyl cysteine and uses thereof |
| CA2899477C (en) * | 2013-02-07 | 2019-09-17 | The Regents Of The University Of Michigan | Thromboresistant/bactericidal s-nitroso-n-acetylpenicillamine (snap)-doped nitric oxide release polymers with enhanced stability |
-
2017
- 2017-02-23 CN CN202411359995.0A patent/CN119185266A/zh active Pending
- 2017-02-23 JP JP2018542710A patent/JP7168958B2/ja active Active
- 2017-02-23 PL PL17757208T patent/PL3419683T3/pl unknown
- 2017-02-23 EP EP17757208.8A patent/EP3419683B1/en active Active
- 2017-02-23 ES ES17757208T patent/ES2899364T3/es active Active
- 2017-02-23 WO PCT/US2017/019136 patent/WO2017147295A1/en not_active Ceased
- 2017-02-23 AU AU2017223689A patent/AU2017223689B2/en active Active
- 2017-02-23 US US16/079,934 patent/US20190054038A1/en not_active Abandoned
- 2017-02-23 CN CN201780013356.0A patent/CN109069701A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20190054038A1 (en) | 2019-02-21 |
| EP3419683B1 (en) | 2021-10-06 |
| WO2017147295A1 (en) | 2017-08-31 |
| EP3419683A1 (en) | 2019-01-02 |
| EP3419683A4 (en) | 2019-10-09 |
| CN109069701A (zh) | 2018-12-21 |
| AU2017223689A1 (en) | 2018-08-16 |
| JP2019506419A (ja) | 2019-03-07 |
| JP7168958B2 (ja) | 2022-11-10 |
| AU2017223689B2 (en) | 2021-05-20 |
| ES2899364T3 (es) | 2022-03-11 |
| CN119185266A (zh) | 2024-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3419683T3 (pl) | Preparaty i zestawy generujące tlenek azotu | |
| ZA201805805B (en) | Formulations and methods | |
| GB2599576B (en) | Methods and compositions for generating nitric oxide and uses thereof | |
| IL264813B (en) | 2-oxo-imidazopyridines and their use | |
| ZA201904704B (en) | Topical cyclosporine-containing formulations and uses thereof | |
| IL253234B (en) | Methods for transdifferentiation and methods to use them | |
| GB201706352D0 (en) | Methods compositions and uses relating thereto | |
| IL261347A (en) | Formulations and printing methods | |
| IL285928A (en) | Fulvestrant formulations and methods of using them | |
| GB201621818D0 (en) | Cosmetic composition and use thereof | |
| GB201706355D0 (en) | Methods compositions and uses relating thereto | |
| IL248934A0 (en) | Topical formulations and their uses | |
| GB201706356D0 (en) | Methods compositions and uses relating thereto | |
| IL268583A (en) | Preparations and methods for use on the skin | |
| IL265531A (en) | N 3 -cyclically substituted thienouraciles and use thereof | |
| GB201608762D0 (en) | Compositions and uses thereof | |
| GB201715785D0 (en) | Methods compositions and uses relating thereto | |
| GB201502268D0 (en) | Dental composition and use | |
| GB201715820D0 (en) | Compositions and methods | |
| GB201705626D0 (en) | Compositions and methods | |
| PT3373976T (pt) | Formulações tópicas e suas utilizações | |
| ZA201807665B (en) | Methods and compositions | |
| GB201614897D0 (en) | Compositions and uses thereof | |
| HK40002856A (en) | Nitric oxide generating formulations and kits | |
| GB201911959D0 (en) | Immunogenic compositions and uses therefor |